Falcarindiol may interact with primed phosphoric acid binding pocket and Gln89‐Asn95 loops on GSK‐3β via hydrogen or covalent bonding to inhibit GSK‐3β in an ATP noncompetitive binding mode and reduce the risk of brain insulin‐resistant AD.182. Here, GSK3B is linked to Alzheimer disease.